Research Paper
Year: 2022 | Month: August | Volume: 9 | Issue: 8 | Pages: 21-30
DOI: https://doi.org/10.52403/ijrr.20220803
Formulation and Evaluation of Famotidine Gastroretentive Floating Tablet by Using Biopolymer
Km Akancha Singh1, Vivek Kumar Patel2, Abhishek Rai3, Rajeev Shukla4
1,2,3,4Saraswati Higher Education and Technology College of Pharmacy Gahani, Varanasi UP India
Corresponding Author: Km Akancha Singh
ABSTRACT
HPMC K4M, HPMC K15M, and HPMC K100M polymers are used in this study to make floating tablets of famotidine hydrochloride. Drug Delivery systems that are floating in the stomach have a lower bulk density than gastric fluids, therefore they stay buoyant in the stomach for a lengthy period of time without impacting gastric emptying rate. In the treatment of gastroesophageal reflex disease (GERD) and peptic ulcer (PUD). Famotidine is a histamine H2 receptor antagonist (GERD). Famotidine is an excellent option for a floating drug delivery system because of its short half-life, brief time in the stomach, and repeated doses. Melt-granulation technique was used to make famotidine floating tablets using HPMC K4M, HPMC K15M, and HPMC K100M. In vitro buoyancy, drug polymer compatibility (IR Research), weight fluctuation, hardness, friability, thickness, drug content and invitro dissolution experiments were all performed on the floating tablets. Using in vitro buoyancy and dissolvability experiments, we were able to establish that the micromeritic characteristic were excellent. HPMC K100M-based formulation F4 has an excellent in vitro buoyancy lag time and floating time, and in vitro dissolution investigations demonstrate a 96.78 percent release for 12 hours. As a result of the findings of this research, it can be concluded that famotidine floating tablets provide the potential for longest- term drug delivery and a consequent reduction in dosage frequency.
Keywords: Gastroretentive floating tablet, Famotidine, Formulation and Evaluation, Biopolymer
[PDF Full Text]